This narrative review highlights the need for a more complete understanding of the ACE2/Ang-(1-7)/MasR axis and the NLRP3 inflammasome to elicit neuroprotection, with or without the setting of COVID-19-mediated ischemic stroke. This evidence concerns the gene MAS1L and COVID-19.